Edition:
India

Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

56.99USD
4 Dec 2020
Change (% chg)

$1.56 (+2.81%)
Prev Close
$55.43
Open
$55.72
Day's High
$56.99
Day's Low
$55.12
Volume
598,942
Avg. Vol
682,617
52-wk High
$60.69
52-wk Low
$39.24

Latest Key Developments (Source: Significant Developments)

Cardinal Health Partners With CDC To Support Vaccine Access For Pharmacies
Thursday, 12 Nov 2020 

Nov 11 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH PARTNERS WITH CDC TO SUPPORT VACCINE ACCESS FOR PHARMACIES.CARDINAL HEALTH INC - REACHED AGREEMENT WITH U.S. CDC TO ACT AS NETWORK ADMINISTRATOR IN PHASE 2 OF FEDERAL PHARMACY PARTNERSHIP STRATEGY FOR COVID-19.CARDINAL HEALTH INC - COVID-19 VACCINE WILL BE DISTRIBUTED BY CDC'S CENTRAL DISTRIBUTOR.  Full Article

U.S. States Seek $26.4 Bln From Drug Companies In Opioid Litigation - WSJ
Tuesday, 18 Aug 2020 

Aug 18 (Reuters) - :U.S. STATES SEEK $26.4 BILLION FROM DRUG COMPANIES IN OPIOID LITIGATION- WSJ.TALKS WITH U.S. STATES INVOLVE MCKESSON, AMERISOURCEBERGEN, CARDINAL HEALTH, JOHNSON & JOHNSON - WSJ.  Full Article

Cardinal Health Files For Potential Mixed Shelf Offering, Size Not Disclosed
Wednesday, 21 Aug 2019 

Aug 20 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED.  Full Article

Cardinal Health, On Opioid Lawsuits, Says Defense & Resolution Of Lawsuits Could Have A Material Adverse Effect On Results Of Operations
Wednesday, 21 Aug 2019 

Aug 20 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH, ON OPIOID LAWSUITS, SAYS DEFENSE & RESOLUTION OF LAWSUITS COULD HAVE A MATERIAL ADVERSE EFFECT ON RESULTS OF OPERATIONS - SEC FILING.CARDINAL HEALTH, ON OPIOID LAWSUITS, SAYS DEFENSE & RESOLUTION OF LAWSUITS COULD HAVE A MATERIAL ADVERSE EFFECT ON FINANCIAL CONDITION - SEC FILING.  Full Article

Cardinal Health Inc Says On August 7, Appointed David Evans As Interim Chief Financial Officer Of Company, Effective September 1, 2019
Thursday, 8 Aug 2019 

Aug 8 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH INC - ON AUGUST 7, APPOINTED DAVID EVANS AS INTERIM CHIEF FINANCIAL OFFICER OF COMPANY, EFFECTIVE SEPTEMBER 1, 2019.CARDINAL HEALTH INC - MICHAEL KAUFMANN WILL CEASE TO BE INTERIM CHIEF FINANCIAL OFFICER ON SEPTEMBER 1, 2019..CARDINAL HEALTH INC - KAUFMANN WILL CONTINUE TO SERVE AS CHIEF EXECUTIVE OFFICER.  Full Article

Cardinal Health Q4 NON-GAAP Earnings Per Share $1.11
Thursday, 8 Aug 2019 

Aug 8 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH REPORTS FOURTH QUARTER AND FULL YEAR RESULTS FOR FISCAL YEAR 2019.Q4 NON-GAAP EARNINGS PER SHARE $1.11.Q4 GAAP EARNINGS PER SHARE $0.65.Q4 REVENUE $37.4 BILLION VERSUS REFINITIV IBES ESTIMATE OF $36.87 BILLION.Q4 EARNINGS PER SHARE ESTIMATE $0.93 -- REFINITIV IBES DATA.SEES FY 2020 NON-GAAP EARNINGS PER SHARE $4.85 TO $5.10.FY2020 EARNINGS PER SHARE VIEW $5.10 -- REFINITIV IBES DATA.GUIDANCE FOR FISCAL 2020 INCLUDES AN ANTICIPATED INCREMENTAL $130 MILLION IN COST SAVINGS.Q4 REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 6 PERCENT TO $33.4 BILLION.CARDINAL HEALTH - TO RECORD RESTRUCTURING CHARGES IN RANGE OF $120 MILLION TO $145 MILLION, MAJORITY OF WHICH ARE EXPECTED TO BE EXPENSED IN FISCAL YEAR 2020.CARDINAL HEALTH HAS TARGETED ACHIEVING MORE THAN $500 MILLION IN SAVINGS WITHIN FIVE YEARS.CARDINAL HEALTH - EXPECTS TO RECORD RESTRUCTURING CHARGES IN RANGE OF $120 MILLION-$145 MILLION, MAJORITY OF WHICH ARE EXPECTED TO BE IN FISCAL YEAR 2020.FY 2020 GUIDANCE RANGE FOR NON-GAAP DILUTED EARNINGS PER SHARE ATTRIBUTABLE TO CARDINAL HEALTH, INC. IS $4.85 TO $5.10.  Full Article

McKesson, Cardinal, Amerisourcebergen Propose Paying $10 Bln To Settle Claims They Helped Fuel Opioid Epidemic - Bloomberg
Tuesday, 6 Aug 2019 

Aug 6 (Reuters) - :DRUG DISTRIBUTORS MCKESSON, CARDINAL, AMERISOURCEBERGEN PROPOSE PAYING $10 BILLION TO SETTLE CLAIMS THEY HELPED FUEL OPIOID EPIDEMIC - BLOOMBERG REPORTER TWEET.  Full Article

Cardinal Health Says Jorge Gomez, CFO, Has Notified Co That He Will Leave Co Effective August 9
Monday, 8 Jul 2019 

July 8 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH INC - JORGE M. GOMEZ, CFO, HAS NOTIFIED CO THAT HE WILL LEAVE CO EFFECTIVE AUGUST 9, 2019 - SEC FILING.CARDINAL HEALTH INC - CEO MICHAEL C. KAUFMANN, 56, WILL ASSUME ADDITIONAL ROLE OF INTERIM CFO EFFECTIVE AUGUST 9.  Full Article

Cardinal Health Sees FY Revenue With Mid-Single Digit Percentage Growth
Thursday, 9 May 2019 

May 9 (Reuters) - Cardinal Health Inc ::SEES FY REVENUE WITH MID-SINGLE DIGIT PERCENTAGE GROWTH.SEES HIGH-SINGLE TO LOW-DOUBLE DIGIT PERCENTAGE DECLINE IN PROFIT FOR PHARMACEUTICAL SEGMENT IN FY.SEES MID TO HIGH-SINGLE DIGIT PERCENTAGE GROWTH IN REVENUE FOR PHARMACEUTICAL SEGMENT IN FY.SEES FY19 MEDICAL SEGMENT PROFIT LOW TO MID-SINGLE DIGIT PERCENTAGE DECLINE.FY2019 REVENUE VIEW $145.18 BILLION -- REFINITIV IBES DATA.  Full Article

Cardinal Health Reports Q3 Results
Thursday, 9 May 2019 

May 9 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH REPORTS THIRD QUARTER RESULTS FOR FISCAL YEAR 2019.Q3 NON-GAAP EARNINGS PER SHARE $1.59.Q3 GAAP EARNINGS PER SHARE $0.99.Q3 REVENUE $35.2 BILLION VERSUS REFINITIV IBES ESTIMATE OF $35.2 BILLION.Q3 EARNINGS PER SHARE ESTIMATE $1.43 -- REFINITIV IBES DATA.RAISES FY 2019 NON-GAAP EARNINGS PER SHARE VIEW TO $5.02 TO $5.17.COMPANY RAISES LOWER END OF FY19 GUIDANCE.COMPANY EXTENDED DISTRIBUTION AGREEMENTS WITH CVS HEALTH THROUGH JUNE 30, 2023.FY2019 EARNINGS PER SHARE VIEW $5.08 -- REFINITIV IBES DATA.Q3 REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 6 PERCENT TO $31.4 BILLION.CARDINAL HEALTH - Q3 REVENUE FOR MEDICAL SEGMENT WAS DOWN 1 PERCENT DUE TO DIVESTITURES OF CHINA DISTRIBUTION AND NAVIHEALTH BUSINESSES.SEES 2019 CAPITAL EXPENDITURES $310 MILLION - $340 MILLION.  Full Article

Photo

McKesson says states seek $21 billion from drug distributors in opioid settlement

McKesson Corp on Tuesday said it and two other major U.S. drug distributors could be expected to pay up to $21 billion under a new proposal to resolve thousands of lawsuits alleging they helped fuel the U.S. opioid crisis.